Early Phase 1 Chronic Fatigue Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For healthy volunteers:
- People aged 18 to 50 who are in good general health, based on their medical history and/or a physical check-up
- People who are willing and able to understand and sign a consent form, and are available to take part for the full duration of the study
For people with ME/CFS:
- People aged 18 to 50 who have a formal diagnosis of ME/CFS that meets at least one of three recognised sets of diagnostic standards: the 1994 Fukuda Criteria, the 2003 Canadian Consensus Criteria, or the Institute of Medicine Diagnostic Criteria
- People who are willing and able to understand and sign a consent form, and are available to take part for the full duration of the study
Who may not be able to join:
For healthy volunteers:
- People who currently have a major neurological or psychiatric condition, such as stroke, Parkinson's disease, Alzheimer's disease, schizophrenia, or major depression
- People who currently have another significant medical condition, such as kidney disease, liver disease, heart disease, or a chronic pain condition, that in the lead researcher's view could make participation unsafe or difficult
- People who are currently taking medications that primarily affect the brain and nervous system, such as antidepressants or stimulants
- People who have used opioid pain medications for more than two weeks at any point in the last two years, or at all in the last month
- People with a current or past history of a substance use disorder, binge drinking, illegal drug use, or heavy tobacco use (more than 10 cigarettes per week)
- People who use cannabis more than occasionally, defined as use on more than one or two days in the last two weeks (confirm with trial site)
- People who use any other illicit drugs or misuse prescription medications (confirm with trial site)
- People with a condition or injury that affects their grip
- People with a condition or injury affecting their arms or legs that would change their skin's sensitivity to heat or cold pain testing, or make such testing unsafe
- People for whom an MRI scan would be unsafe — for example, those with metal in the skull or eye, an implanted nerve stimulator, cochlear implant, cardiac pacemaker, defibrillator, or implanted pump; those with non-removable body piercings; those with claustrophobia; those unable to lie still for 90 minutes; or those who are pregnant or planning to become pregnant during the study
- Staff members of the NINDS Brain Network Unit (BNU) and their immediate family members
- People who do not speak English, as some of the study tools have not been validated in other languages
For people with ME/CFS:
- People who have a major neurological or psychiatric condition in addition to their ME/CFS, such as stroke, Parkinson's disease, Alzheimer's disease, schizophrenia, or major depression
- People who have another significant medical condition in addition to their ME/CFS, such as kidney disease, liver disease, heart disease, or a chronic pain condition, that in the lead researcher's view could make participation unsafe or difficult
- People who are currently taking psychomotor stimulants, antipsychotics, or benzodiazepines
- People who have used opioid pain medications for more than two weeks at any point in the last two years, or at all in the last month
- People with a current or past history of a substance use disorder, binge drinking, illegal drug use, or heavy tobacco use (more than 10 cigarettes per week)
- People who use cannabis more than occasionally, defined as use on more than one or two days in the last two weeks (confirm with trial site)
- People who use any other illicit drugs or misuse prescription medications (confirm with trial site)
- People with a condition or injury that affects their grip
- People with a condition or injury affecting their arms or legs that would change their skin's sensitivity to heat or cold pain testing, or make such testing unsafe
- People for whom an MRI scan would be unsafe — for example, those with metal in the skull or eye, an implanted nerve stimulator, cochlear implant, cardiac pacemaker, defibrillator, or implanted pump; those with non-removable body piercings; those with claustrophobia; those unable to lie still for 90 minutes; or those who are pregnant or planning to become pregnant during the study
- Staff members of the NINDS Brain Network Unit (BNU) and their immediate family members
- People who do not speak English, as some of the study tools have not been validated in other languages
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eric M Wassermann, M.D., National Institute of Neurological Disorders and Stroke (NINDS)
Phone: (301) 480-9787
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Determine which regions of the SVN are specifically involved in the subjective experience of unpleasantness associated with sensations of pain.; Determine which regions of the SVN are specifically involved in the subjective experience of unpleasantness associated with sensations of physical effort.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.